Publications and Digital Products

This Advisory is based on TIP 50, Addressing Suicidal Thoughts and Behaviors in Substance Abuse Treatment. It provides strategies for identifying and addressing suicidal thoughts and behaviors among individuals with substance use disorders (SUDs).

This Advisory highlights how mental and substance use disorder treatment programs can better serve people with physical and cognitive disabilities and substance use disorders (SUDs) and/or serious mental illness (SMI).

This Advisory can help clinicians who work in a mental health facility implement a tobacco cessation program to reduce the use of tobacco-related products and tobacco-related diseases among clients with SMI.

This paper examines what is known about suicide clusters within American Indian and Alaska Native (AI/AN) populations and uses that information to provide recommendations for stakeholders working to prevent and contain suicide clusters within AI/AN communities.

This advisory discusses the interaction between obsessive-compulsive disorder (OCD) and substance use disorder. It provides clinicians with an overview of screening and evidence-based treatments for OCD.

This advisory gives an introduction to bipolar disorder and co-occurring substance use disorder. It discusses types of bipolar disorders along with the challenges in screening and treatments.

This brief highlights issues specific to Asian American, Native Hawaiian, and Pacific Islander males. It provides clinicians with data on the prevalence of depression, suicide, and substance use disorders within these populations.

This advisory for behavioral health practitioners provides a brief overview of complementary health approaches. It describes the practices and products that are considered complementary, and explains how practitioners can help patients understand the benefits and risks.

This advisory defines attention deficit hyperactivity disorder in adults, and explains interactions with substance use disorders.

This advisory provides information about screening for Hepatitis C. It defines Hepatitis C and discusses its prevalence and transmission. The advisory also describes methods for treatment, testing, and counseling.